Cortagen vs Crystagen China Supplier 20mg Guide

Create two independent sequence specifications

For each material, write the full buyer-approved amino-acid sequence, residue order, termini, modifications and counterion form where applicable, expected molecular information, target purity, nominal 20mg content, quantity and Research Use Only status. Record Cortagen, Crystagen and any letter-code aliases separately. Require distinct product codes and ensure each quotation, specification, COA, analytical sample, label and packing list maps to the correct controlled identity. A short name or common bioregulator category is not sufficient proof of sequence.

Resolve marketplace sequence conflicts before quotation

Current supplier pages do not always describe short bioregulator sequences consistently. Compare every residue, terminal group, expected mass and synonym against an approved reference instead of copying the first search result. A single residue difference creates a different peptide even if both items are 20mg white lyophilized materials. Do not accept Bronchogen, Cardiogen, Cartalax or another neighboring product as a synonym. Any alternative construct should become a new line item requiring technical review, not an informal substitution.

Review HPLC and MS files product by product

Require complete batch-linked chromatographic and mass-spectrometric evidence for each product. Check the sample identifier, expected and observed molecular information, chromatogram, integration, method reference, test dates, report number and authorization. Ask how the tested sample connects to bulk material and finished 20mg units. One product's report cannot qualify the other. HPLC area purity does not prove sequence or quantity, while a mass match alone cannot establish residue order, purity, finished-vial content or every modification.

Keep purity and 20mg content as separate fields

Ask which quantitative method or controlled filling record supports 20mg for Cortagen and for Crystagen and what tolerance applies. Confirm whether the amount means net target peptide or total lyophilized mass including water, counterions or excipients. Maintain independent acceptance fields for sequence identity, chromatographic purity and quantitative content. If both products are filled in one campaign, require documented line clearance, reconciliation and label control. Compare offers by total documented target material after the evidence basis is aligned.

Prevent cross-labeling in mixed wholesale orders

Approve product-specific labels showing the full name, strength, lot and RUO wording. Use full names instead of similar internal codes on purchase orders, pick lists and receiving records. Map seller, synthesis site, laboratory, filler, release authority, inventory owner and shipper. Confirm released stock, MOQ, lead time and change notification separately. At receipt, segregate the two SKUs and quarantine any swapped name, sequence, lot, strength or certificate until a traceable supplier investigation is complete.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• Cortagen 20mg
• Crystagen 20mg
• Cardiogen vs Cartalax Guide
• Bronchogen Supplier Guide

Frequently asked questions